Navigation Links
Scientists detect presence of marburg virus in african fruit bats
Date:8/21/2007

A collaborative team of scientists reported findings today demonstrating the presence of Marburg virus RNA genome and antibodies in a common species of African fruit bat (Rousettus aegyptiacus).

Appearing in the open-access scientific journal PLoS ONE, the study is the first in which RT-PCR and serological findings have both affirmed Marburg infection in a specific bat species. The natural reservoir for Marburg virus has been the subject of much speculation and scientific investigation. In demonstrating evidence of infection in this common species of fruit bat, the paper provides new insight into a deadly disease that has long baffled epidemiologists, ecologists and virologists, and in which the public has shown a sustained interest.

The work was done in collaboration between the Centers for Disease Control and Prevention (CDC), Atlanta, GA, and the Centre International de Recherches Mdicales de Franceville (CIRMF) and the Institut de Recherche pour le D veloppement, Franceville, Gabon.

Identifying Marburg infection in the African fruit bats brings us one step closer to understanding this deadly disease, says Dr. Eric Leroy of CIRMF, corresponding author on the paper.

Marburg virus and the related Ebola virus have caused large outbreaks with high case fatalities (80-90%) in humans and great apes. No vaccine or drug therapy is available presently. The paper reports detection of viral RNA from four out of 283 R. aegyptiacus bats in a collection of over 1100 bats tested, representing 10 species. Interestingly, 29 of 242 R. aegyptiacus bats also tested serologically positive for Marburg virus as evidenced by the presence of IgG antibodies in bat sera. Neither Marburg virus RNA nor specific antibody were detected in any of the other species of bats tested. All bats were trapped near caves in 2005 and 2006 in Gabon and the Republic of Congo. Genetic sequences obtained from the infected bats in this study are unique compa
'/>"/>

Contact: David Daigle
drd4@CDC.GOV
404-639-1143
Public Library of Science
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Nobel Prize for Medicine shared by Three scientists
2. Scientists plan human cloning clinic in the United States
3. Scientists crack dengue fever puzzle
4. Scientists found ancient Human Germ Killer
5. Scientists locate key hormone involved in appetite control
6. Scientists open the book of life
7. Electronic nose by Italian scientists
8. Scientists review SARS
9. Scientists push to lower hidden sodium in food
10. Indian Scientists Make Wide-Ranging Analysis And Annotation Of X Chromosome
11. Scientists have found effective brain regions for deep brain stimulation for Parkinson’s

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...again commits to SAS70 Audit to demonstrate SOX an...WEB) November 25, 2009 -- Partners Consulting Serv...ion has completed the American Institute of Certif...g Standards (SAS) No. 70 type II audit. SAS 70 is ... the internal controls of service providers and ot...
(Date:11/25/2009)... basketball organization has selected a full roste...py, technology, and learning as part of their visi... Center. After a year of research and evaluation, ...quatic training; the selection of flagship hydroth...ydroWorx 2000 Series, an elite training tool, pack...
(Date:11/24/2009)...ation oncologists use advanced imaging techniques ...gnetic resonance imaging (MRI), and 4-dimensional ...(to locate the tumor and other areas at risk for h...mber issue of the Journal of the American College...efining the target, the radiation oncologist draws...
(Date:11/24/2009)...swire/--EnigmaDiagnosticsLimited,thedecentraliseda...edtodayfourseniorappointmentsforitsUSandEuropeanof...identandCEOwithGregHamilton,ChiefOperatingOfficera...U.S.headquartersinSanDiego,California,theheadquart...edforassaydevelopment,R&Dandcommercialactiviti...
(Date:11/24/2009)...TheBaylorCharlesA.SammonsCancerCenterhasbecomeaful...ativegroupsintheUnitedStates.Fundedbyresearchgrant...roupconductsclinicaltrialstopreventandtreatcanceri...vors. ,, "Joiningthisprestigiousgroupwillallowu...patientsinNorthTexas,"saidAlanM.Miller,M.D.,Ph.D.,...
Breaking Medicine News(10 mins):Health News:Partners Consulting Completes SAS70 Audit 2Health News:Oklahoma Thunder Inserts HydroWorx into Line-Up at Integris Health Center 2Health News:Oklahoma Thunder Inserts HydroWorx into Line-Up at Integris Health Center 3Health News:Enigma Diagnostics Expands Its US and European Executive Management Teams 2Health News:Enigma Diagnostics Expands Its US and European Executive Management Teams 3Health News:Baylor Sammons Cancer Center Joins One of Nation's Largest Cancer Clinical Trials Groups 2
...e 20 Bob Hamilton was named Vice,President of Ham...comes to,Hamilton Medical with a financial backgro... utilized by such companies as Smith Barney,Citigr...forward to great things for the future., (Phot...
... -- The Damon Runyon Cancer Research Foundation na...ts May 2008 Clinical Investigator Award Committee ...-year award are outstanding early career physician...ns. Each will receive $450,000 to support the dev...
...- The American College of Physicians (ACP) today c...(MedPAC) for its recognition of the importance of ...ivery system in its June 2008 Report to Congress. ...ss on issues affecting the Medicare program. ,In a...
...ents should think carefully about test that has no...une 20 (HealthDay News) -- While CT screening may ...ormer smokers, it won,t reduce the risk of death f... from 1,520 current and former smokers who took pa...
...C., June 20 Blockbusters are not,discovered, they...start,early, listen carefully, and spend wisely. T...ma product launches, top performers have developed...unching a Blockbuster: The Making,and Marketing of...
... US $50 Million over a Five-Year Period to Improve...ARCH TRIANGLE PARK, N.C., June 20 The,U.S. Agency...ed that Family,Health International (FHI) -- a glo...ning Services)., The project will generate knowle...
Other Medicine News:Health News:Damon Runyon Cancer Research Foundation awards $2.25M to 5 top young clinical investigators 2Health News:Damon Runyon Cancer Research Foundation awards $2.25M to 5 top young clinical investigators 3Health News:American College of Physicians commends MedPAC June 2008 report to Congress 2Health News:American College of Physicians commends MedPAC June 2008 report to Congress 3Health News:CT Screens for Lung Cancer Not a Cure-All 2Health News:Family Health International Awarded USAID 'Progress' Project to Improve Family Planning and Reproductive Health Programs in Developing Countries 2Health News:Family Health International Awarded USAID 'Progress' Project to Improve Family Planning and Reproductive Health Programs in Developing Countries 3
(Date:11/24/2009)...MFORD,Conn.,Nov.24/PRNewswire/--ZargisMedicalCorp....offfromSiemensCorporateResearch(NYSE: SI ),todayan...heNovember24,2009episodeofCBS, TheEarlyShow during...ce magazine,reviewedfivewinningproductsfromthepubl...rlyShow isawidely-viewedtelevisionmorningnewstalks...
(Date:11/24/2009)...DIEGO,Nov.24/PRNewswire/--AmbitBiosciencesCorporat...onsevaluatingAC220,anovelsecondgenerationFLT3inhib...alMeeting(ASH)tobeheldinNewOrleans,LA,December5-8,...ngoingclinicalPhaseImonotherapysafetystudyinadults...nicaldatawillbepresentedevaluatingtheeffectofAC220...
(Date:11/24/2009)...NKLIN,Mass.,Nov.24/PRNewswire-FirstCall/--EchoTher...opingitsneedle-freeSymphony(TM)tCGMSystemasanon-in...ring(tCGM)systemanditsPrelude(TM)SkinPrepSystemfor....Mooney,M.D.,ChairmanandChiefExecutiveOfficer,will...ticalsConference,sponsoredbytheNewYorkSocietyofSec...
Breaking Medicine Technology:Zargis Cardioscan(TM) Featured on The Early Show on CBS 2Zargis Cardioscan(TM) Featured on The Early Show on CBS 3Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting 2Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting 3Echo Therapeutics to Present at the New York Society of Security Analysts' 13th Annual Biotech and Specialty Pharmaceuticals Conference 2Researchers find demand for cosmetic and surgical procedures in dermatologic surgery rising rapidly 58874 1Researchers find demand for cosmetic and surgical procedures in dermatologic surgery rising rapidly 58874 2World first sustainable racing car to take on Formula 3 at Brands Hatch 10262 1Northeast Indiana Regional Partnership to Participate in 2009 Orthopedic Design 26amp 3B Technology Conference 26amp 3B Exhibition 14354 1Northeast Indiana Regional Partnership to Participate in 2009 Orthopedic Design 26amp 3B Technology Conference 26amp 3B Exhibition 14354 2Northeast Indiana Regional Partnership to Participate in 2009 Orthopedic Design 26amp 3B Technology Conference 26amp 3B Exhibition 14354 3
...ch 3 ,GlaxoSmithKline (NYSE: GSK ; LSE) today ann...stration has granted Priority Review for PROMACTA(...atients with chronic,idiopathic thrombocytopenic p...daily oral treatment that induces the production o...which are critical in minimizing the,incidence of ...
...stically Significant Pain Relief with the 2.5 ... MOUNTAIN VIEW, Calif., March 3 Alexza,Pharmaceut...ive top-line,results from its 168 patient Phase 2a...n patients with migraine headache. Migraine is a d...cterized by attacks of severe,headache and autonom...
Other Medicine Technology:FDA Grants Priority Review for PROMACTA(R) (eltrombopag) 2FDA Grants Priority Review for PROMACTA(R) (eltrombopag) 3FDA Grants Priority Review for PROMACTA(R) (eltrombopag) 4Alexza's AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache 2Alexza's AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache 3Alexza's AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache 4Alexza's AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache 5Alexza's AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache 6Alexza's AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache 7Alexza's AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache 8
...Since its introduction in 1958, Bard mesh has beco...re compared. Bard mesh was used by Dr. Irving Lich..." hernia repair many years ago. Lichtenstein descr... permanent reinforcement of hernia repair. As an a...
...The Bard PerFix plug technique, recommended for th...and direct inguinal hernias, provides significant ...equiring less overall dissection and is utilized i...sult is increased patient comfort, fast rehabilita...
...The Company's Aura-i Laser System is a compact, hi...r office-based procedures. Its unique, integrated ...enign vascular, including telangiectasia on the le...ng leg veins. It can also be used as a continuous ...
...The Gemini is the newest addition to Laserscopes f... distinct wavelengths to choose from, 1064nm Nd:YA...ding non-invasive aesthetic laser market by pushin...ness while maintaining the safety and reliability ...
Medicine Products: